ArticleBriefings in bioinformatics2026
CRISPR-MBTF: a multi-branch transformer fusion framework for CRISPR-Cas9 off-target prediction.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR-Cas9) is a revolutionary genome editing technology derived from a bacterial adaptive immune system that uses a single guide RNA (sgRNA) to direct the Cas9 enzyme to specific DNA sequences for precise genetic modifications. Its ease of use and efficiency has accelerated advancements in genetic research and therapeutic development. However, unintended cleavage at off-target sites remains a significant concern, limiting the safety and broader applicability of CRISPR-based editing. Accurate computational prediction of off-target locations is therefore essential to mitigate potential risks and improve experimental design. In this study, we introduce CRISPR multi-branch transformer fusion (CRISPR-MBTF), a novel deep learning-based framework employing a multi-branch Transformer architecture combined with an attention-based fusion mechanism to model the intricate biological context influencing CRISPR activity. By capturing subtle sequence patterns and contextual dependencies, our model achieves enhanced predictive performance compared to existing approaches. Additionally, interpretability analyses uncover biologically meaningful patterns and highlight influential sequence regions, offering valuable insights into the determinants of CRISPR specificity. This work presents a robust and interpretable tool to support the design of safer and more effective genome editing strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.